Pitolisant Effects on Affect & Cognition Exploratory Study (PEACE Study)

Status Completed

Clinical Trial Summary

The goal of this study is to investigate the effects of selective histamine 3 antagonist pitolisant on brain function and cognition in healthy individuals. The main questions it aims to answer are: 1. Does pitolisant alter functional activity in brain regions linked to reward and cognitive processing during rest or cognitive task performance? 2. Does pitolisant alter cognitive ability across a range of psychological domains, including working memory, executive functioning and emotional processing? Participants will undertake fMRI scanning in addition to a battery of tasks designed to measure cognitive and emotional processing after taking a single dose of pitolisant or placebo. Researchers will compare differences in functional activity, cognition and emotional processing across the pitolisant and placebo groups.

Clinical Trial Description

Cognitive and affective processing are underpinned by monoaminergic neurotransmission and neurosteroid systems, yet there are many aspects of these systems that remain unknown in humans. In particular, monoaminergic histamine 3 (H3) receptors are abundant in CNS regions underpinning cognitive processing (prefrontal cortex, hippocampus, and striatum), yet the role of these receptors in humans remains unclear. Evidence from animal models suggests H3R antagonism improves cognitive functioning, however these specific effects are yet to be examined in humans. Similarly, the function of sigma-1 (σ-1) receptors in the brain is not well understood in humans despite strong evidence of pro-cognitive effects in animal models. The study will investigate the effect of pitolisant, a dual H3R antagonist and σ-1R agonist, on cognitive and affective processing, in addition to changes in functional connectivity. These effects will be measured with a battery of neuropsychological tasks (e.g., Affective Go/No-Go Task; Adaptive dual n-back task), self-rated measures of cognitive function (PDQ), and resting state fMRI and fMRI data acquisition during the verbal n-back and memory encoding tasks. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05849675
Study type	Interventional
Source	University of Oxford
Contact
Status	Completed
Phase	N/A
Start date	April 1, 2023
Completion date	May 8, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05563805` - Exploring Virtual Reality Adventure Training Exergaming	N/A
Completed	`NCT03708692` - Menstrual Cycle Phases on Recovery and Cognitive Function
Active, not recruiting	`NCT04505345` - Virtual Reality Cognitive Training in Alcohol Use Disorder	N/A
Completed	`NCT04430465` - Effects of Wholegrains on Children's Health (KORN)	N/A
Completed	`NCT02915913` - Effects of Exercise Training on Cognitive Function and Neurotrophic Factors in Overweight Adults	N/A
Completed	`NCT01410097` - Physical and Cognitive Function - Look AHEAD Ancillary Study	N/A
Completed	`NCT03826121` - Efficacy and Safety of Sesame Oil Cake Extract on Improvement of Cognitive Function	N/A
Recruiting	`NCT05621278` - Children to Adults Mental and Psychosomatic Health Study (CAMPS)
Completed	`NCT05498415` - Feasibility, Acceptability, and Efficacy of the Sleep Move Stand Study	N/A
Completed	`NCT03208569` - Anticholinergic Burden - Treatment Optimization
Completed	`NCT03793777` - The Effect of Aronia Melanocarpa Extract on Cognitive Function	N/A
Recruiting	`NCT05525299` - Reminiscence-Based Life Review on Copying With Existential Suffering Among Older Cancer Survivors	N/A
Completed	`NCT03698123` - Performance Nutrition for Residents and Fellows	N/A
Completed	`NCT04543500` - Self-regulation of Prefrontal Cortex During Emotional Cognitive Control	N/A
Recruiting	`NCT05891977` - Effect of Tomato Paste Consumption on the Microbiota-gut-brain Axis in Healthy Adults	N/A
Recruiting	`NCT05591885` - Nutrilite Memory Builder on the Improvement of Cognitive Function	N/A
Active, not recruiting	`NCT05575752` - Acute Health Effects of High Temperature Exposure	N/A
Completed	`NCT03716609` - Effects of Magnesium Supplementation on Hemodynamic Parameters and Cognitive Function	N/A
Completed	`NCT02763514` - The Effects of DHA- and EPA-enriched Oils on Cognitive Function and Mood	N/A
Completed	`NCT02675621` - Investigation of Acute Mood and Cognitive Performance Effects of Beverages Containing Phenolics in Healthy Adults	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Pitolisant Effects on Affect and Cognition Exploratory Study (PEACE Study) — PEACE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms